HHS Vows to Ensure Continued Availability of Paxlovid in Commercial Market Transition
The Department of Health and Human Services (HHS) has announced a new agreement with Pfizer that ensures continued access to the antiviral medication Paxlovid for the next few years. This agreement comes as the drug is being prepared for transition into the commercial market. HHS emphasized that this agreement aims to maximize the investment made …